Skip to main content
. Author manuscript; available in PMC: 2016 Nov 14.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):e34–e40. doi: 10.1097/QAI.0000000000000264

TABLE 3.

ART Eligibility Determination and Timing of ART Initiation, by Facility Type

PHF (n = 3881) SHF (n = 22,809)
n (%) n (%) P
Patients with ART eligibility ascertained:
 At enrollment in HIV care* 2246 (57.9) 12,402 (54.4) <0.001
 Within first 3 mo of HIV care 2601 (67.0) 14,162 (62.1) <0.001
 Within first 6 mo of HIV care 2768 (71.3) 14,854 (65.1) <0.001
Patients determined to be ART eligible within first 6 mo of HIV care 1521 (54.9) 9647 (64.9) 0.0003
Among patients who were ART eligible at enrollment* 1268 (56.5) 8208 (66.2) <0.0001
 Initiated ART within 30 days 472 (37.2) 3060 (37.3) 0.97
 Initiated ART within 6 mo 910 (71.8) 5181 (63.1) <0.0001
*

ART eligibility at enrollment was ascertained using CD4 and WHO staging information collected within 90 days before and 30 days after the enrollment date.

Percentage among patients with eligibility ascertained.

Percentage of patients screened for ART eligibility who were determined to be eligible at enrollment.